Table 1. Clinico-pathological characteristics of the validation set (26 Patients & 36 Samples).
Sample ID | Age | Sex | Type of Tissue | Location | TNM | STAGING |
---|---|---|---|---|---|---|
CC1018N | 84 | F | N | RIGHT | N | NA |
CC1018 | 84 | F | T | LEFT | T3N1b | II |
CC1024 | 73 | F | T | RIGHT | T3N1MX | III |
CC1028 | 42 | M | T | LEFT | T3N0MX | II |
CC1028N | 42 | M | N | RIGHT | N | NA |
CC1029 | 51 | F | T | RIGHT | T2N0MX | II |
CC1029N | 51 | F | N | LEFT | N | NA |
CC1036 | 63 | M | T | LEFT | T3N2M1 | IV |
CC1036N | 63 | M | N | RIGHT | N | NA |
CC1038 | 54 | M | T | LEFT | T3N0Mx | II |
CC1038N | 54 | M | N | RIGHT | N | NA |
CC1053 | 50 | F | T | RIGHT | T3N0M0 | II |
CC1053N | 50 | F | N | LEFT | N | NA |
CC1054 | 53 | M | T | RIGHT | T3N0M0 | II |
CC1054N | 53 | M | N | LEFT | N | NA |
CC1055 | 79 | F | AA | RIGHT | AA | NA |
CC1056 | 66 | M | T | LEFT | T1N1MX | III |
CC1056N | 66 | M | N | RIGHT | N | NA |
CC1057 | 88 | M | T | LEFT | T3N2M0 | III |
CC1057N | 88 | M | N | RIGHT | N | NA |
CC1059 | 60 | F | T | RIGHT | T3N1MX | II |
CC1060 | 53 | F | T | LEFT | T3N2M1 | IV |
CC1060N | 53 | F | N | RIGHT | N | NA |
CC1061 | 63 | M | N | LEFT | N | NA |
CC1065 | 41 | M | T | LEFT | T3N0M0 | II |
CC1109 | 62 | F | A | RIGHT | A | NA |
CC1258 | 52 | M | T | RIGHT | T3N1bMx | III |
CC1386 | 70 | M | T | LEFT | T3N0Mx | II |
CC1621N | 49 | M | N | RIGHT | N | NA |
CC1680 | 75 | F | AA | RIGHT | AA | NA |
CC1681 | 75 | M | AA | LEFT | AA | NA |
CC1682 | 71 | M | AA | RIGHT | AA | NA |
CC1683 | 45 | M | A | RIGHT | AA | NA |
CC1698 | 54 | M | A | RIGHT | A | NA |
CC1720 | 70 | F | A | RIGHT | A | NA |
CC1721 | 54 | M | A | Missing | A | NA |
N = Normal, T = CRC, A = Adenoma, AA = Advanced Adenoma